Annis Gardner Whiting Capital Advisors’s Globus Medical GMED Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-225	Closed	-$19.4K	–	698
2026 Q1	$19.4K	Hold	225	–	–	﹤0.01%	740
2025 Q4	$19.6K	Buy	225 +83	+58%	+$6.3K	﹤0.01%	658
2025 Q3	$8.13K	Sell	142 -233	-62%	-$13.4K	﹤0.01%	733
2025 Q2	$22.1K	Buy	375 +233	+164%	+$15.1K	0.01%	550
2025 Q1	$10.4K	Hold	142	–	–	﹤0.01%	537
2024 Q4	$11.7K	Hold	142	–	–	﹤0.01%	512
2024 Q3	$10.2K	Hold	142	–	–	﹤0.01%	545
2024 Q2	$9.73K	Hold	142	–	–	﹤0.01%	689
2024 Q1	$7.62K	Hold	142	–	–	﹤0.01%	707
2023 Q4	$7.57K	Hold	142	–	–	﹤0.01%	502
2023 Q3	$7.05K	Buy	+142	New	+$7.94K	﹤0.01%	498

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's GMED Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 225 shares — an estimated $19.4K sold.

Annis Gardner Whiting Capital Advisors first reported a position in GMED in Q3 2023 and held it in 11 quarters. The position peaked at $22.1K in Q2 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Annis Gardner Whiting Capital Advisors reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Annis Gardner Whiting Capital Advisors sold 225 Globus Medical shares in Q2 2026, an estimated $19.4K.
Annis Gardner Whiting Capital Advisors first reported a position in Globus Medical in Q3 2023 and held it in 11 quarters.
Annis Gardner Whiting Capital Advisors's Globus Medical position peaked at $22.1K in Q2 2025.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.